Cambridge Cognition Holdings Plc (LON:COG – Get Free Report)’s share price was down 9.7% on Tuesday . The company traded as low as GBX 27 ($0.35) and last traded at GBX 28 ($0.37). Approximately 156,567 shares changed hands during mid-day trading, an increase of 172% from the average daily volume of 57,464 shares. The stock had previously closed at GBX 31 ($0.40).
Cambridge Cognition Price Performance
The stock has a market capitalization of £11.74 million, a price-to-earnings ratio of -700.00 and a beta of 0.72. The company has a current ratio of 0.65, a quick ratio of 0.96 and a debt-to-equity ratio of 92.53. The stock has a 50-day moving average price of GBX 39.88 and a 200 day moving average price of GBX 43.42.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Featured Stories
- Five stocks we like better than Cambridge Cognition
- Investing In Automotive Stocks
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
